Abstract
Vaginal microbiota involves seven communities-state types (CST), four dominated by Lactobacillus. L. crispatus, particularly, offers enhanced protection against infections. Recurrent vulvovaginal candidiasis and trichomoniasis affect millions of people annually, often asymptomatically, facilitating infection spread and leading complications. Co-culture, the technique of cultivating different microbial populations together to mimic real-life conditions, enables the study of microorganism interactions, including inhibitory or promotive effects on pathogens. This review compiles data on co-culture techniques to analyze interactions among Lactobacillus spp., Candida spp., and Trichomonas vaginalis. PubMed was searched using medical subject headings (MESH) terms, ‘co-culture’, ‘coculture,’ ‘cocultivation,’ ‘co-incubation,’ and ‘Trichomonas vaginalis’, ‘Candida spp.’, ‘Lactobacillus spp.’. Articles were selected based on relevance to vaginal health, English language, availability, and use of co-culture or co-incubation techniques in the past 24 years. Co-culture and co-incubation studies over the past 24 years have advanced our understanding of microbiota-host, pathogen-host, and pathogen-host-microbiota interactions. These studies reveal that microbiota composition impacts infections, with the microbiota producing substances against pathogens and pathogens developing stress tolerance mechanisms. They elucidate pathogen virulence factors, interactions with immune cells, and how ecological relationships between microorganisms can enhance pathogenicity.
Keywords: Candida spp., co-culture, Lactobacillus spp., Trichomonas vaginalis, vaginal health, vaginal microbiota
Abbreviations
AMPs - antimicrobial peptides,
BV - bacterial vaginosis,
CFU - colony forming unit,
CLM - communal liquid growth medium,
CLSM - confocal laser scanning microscopy,
CSTs - communities-state types,
GBS - Group B Streptococcus,
hECs - ectocervical cells,
ROS - reactive oxygen species,
SEM - scanning electron microscopy,
STI - sexually transmitted infection,
VVC - vulvovaginal candidiasis.
INTRODUCTION
The human body harbors a complex microbial community, known as microbiota, which plays a crucial role in influencing overall health, including functions related to immunity, nutrition, and disease susceptibility 1. In the vaginal environment, factors such as oxygen levels, glucose, iron, and nutrients create conditions conducive to supporting diverse microbial populations 2. Culture-dependent techniques have long studied vaginal microbiota, but OMICS technologies now allow for the identification of previously uncultivable microorganisms. This advancement has characterized the vaginal microbiota into seven community-state types (CSTs), with four dominated by Lactobacillus species. CST-I is dominated by Lactobacillus crispatus, CST-II by Lactobacillus gasseri, CST-III by Lactobacillus iners, and CST-V by Lactobacillus jensenii 3. The presence of L. crispatus is particularly associated with enhanced protection against infections 4. In contrast, a dysbiotic vaginal microbiota lacking Lactobacillus enriched with anaerobes can lead to bacterial vaginosis and is linked to infections like trichomoniasis and vulvovaginal candidiasis (VVC) 5,6.
The vaginal microbiota includes a fungal community with Candida albicans as the most prevalent species, which can colonize without causing infection 7. The presence of C. albicans increases the risk of vaginitis due to immune imbalance, dysbiosis, or epithelial barrier breaches. This opportunistic pathogen can proliferate, leading to VVC, the second most common cause of vaginitis 8. Recurrent vulvovaginal candidiasis (RVVC), often caused by C. albicans, affects 138 million women annually and severely impacts quality of life and incurs high costs 9. VVC has demonstrated an escalation in drug resistance, particularly against the primary therapeutic option, fluconazole 10. This characteristic, where Candida can either be a part of women’s normal microbiota or act as the etiological agent of VVC, is attributed to its dimorphic nature 11.
The first line of defense against C. albicans is mediated by the innate immune system, which recognizes the fungus through phagocytic receptors 12. Neutrophils and macrophages engulf C. albicans by phagocytosis, trapping it within a phagosome and exposing it to antimicrobial peptides (AMPs), reactive oxygen species (ROS), and other fungicidal factors 13,14. However, C. albicans has developed mechanisms to evade the immune detection, escape from phagosomes, and resist immune cell killing 15. Additionally, epithelial cells secrete AMPs and pro-inflammatory cytokines, which play a crucial role in recruiting neutrophils to the infection site 16,17. To survive this, C. albicans produces candidalysin, a toxin that damages host cell, further complicating the immune response 18.
Trichomoniasis, another form of vaginitis, is the most common non-viral sexually transmitted infection (STI), caused by the flagellated protozoan Trichomonas vaginalis, with an estimated annual incidence of 156 million new cases 19. Approximately 80% of individuals infected are asymptomatic or experience minimal symptoms, leading to complications for affected individuals and facilitating the spread of the protozoan 20. These complications stem from the intricate parasite-host relationships, driven by T. vaginalis capability to engage in phagocytosis, cytoadherence, and cytotoxicity, whether through contact-dependent or independent-contact mechanisms 21. Concerningly, resistance of T. vaginalis isolates to 5-nitroimidazole-class drugs, the current treatment of choice, was documented merely three years after FDA approval for their use 22.
Similar to C. albicans, the initial immune response against T. vaginalis is mediated by innate immune system, involving neutrophils, myeloid cells, and the complement system 23. T. vaginalis employs immune modulation to establish and sustain infection. Its interaction with neutrophils reduces chemokine production and immune cell recruitment, while also promoting neutrophil apoptosis and increasing ROS production 24. To colonize the urogenital tract, T. vaginalis needs to adhere to vaginal epithelial cells through degrading the protective mucus layer 25. Following adhesion, the parasite initiates cytotoxicity, a process involving cytolysis, phagocytosis, and the disintegration of the epithelial monolayer, facilitating nutrient acquisition and immune evasion 26.
This review updates co-culture and co-incubation techniques for studying interactions of Lactobacillus spp., representing a predominant member of the healthy vaginal microbiota; Candida spp., the most abundant yeast in the vagina, and T. vaginalis, responsible for the most widespread nonviral STI worldwide. These microorganisms were co-incubated or co-cultured with other microorganisms related to STIs, vaginal microbiota, vaginal cells, or immune cells to assess vaginal health. This review explores two approaches: communal liquid medium growth (CLM), which includes direct mixing or biofilm formation, and membrane separation methods like the Transwell® system. Table 1 summarizes these studies. We define co-incubation as short-term interactions (up to 24 h) and co-culture as longer interactions (over 24 h), considering the differences in doubling rates between the studied microorganisms and human cells 27,28. T. vaginalis replicates every 4-6 h 29, C. albicans every 3-4 h 30, and Lactobacillus species approximately every 1 h 31, whereas human cells have a slower doubling time of around 24 h 32. The terms co-culture and co-incubation were retained as used by the original authors, even if their application was inconsistent.
Table 1.
Summary co-incubation/co-culture studies on sexually transmitted infections (STIs) microorganisms, vaginal microbiota, vaginal cells, and immune cells.
BV, Bacterial vaginosis; VVC, Vulvovaginal candidiasis; HeLa, Cervical cancer cell; TV, Trichomonas vaginalis; SEM, Scanning electron microscopy; TEM, Transmission electron microscopy; CFU, Colony forming units assay; CLSM, Confocal laser scanning microscopy; ECL, Electrochemiluminescence; ELISA, Enzyme-linked immunosorbent assay; LDH, Lactate dehydrogenase assay; PCR, Polymerase chain reaction; RT-qPCR, Reverse transcription and quantitative PCR; TvMIF, T. vaginalis macrophage migration inhibitory factor; XTT, 2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; H2O2, Hydrogen peroxide; GBS, Group B Streptococcus; CFS, Cell-free supernatants; Ref., References.
| Microorganisms/Disease | Host Cell type | Co-incubation or Co-culture? | Techniques for evaluating microbial cultures | Interaction | Key findings | Ref. |
| Pseudomonas aeruginosa, Candida albicans, C. tropicalis, C. parapsilosis, C. krusei, C. dubliniensis and C. glabrata/Mixed biofilms | - | Co-culture |
CFU counts CLSM SEM |
Dual species biofilm (Bacteria-Yeast) | Mutual inhibition of biofilm formation | 61 |
| T. vaginalis, Gardenerella vaginalis, Prevotela bivia, Lactobacillus acidophilus, L. crispatus and L. jensenii/Trichomoniasis and BV | Epithelial cells lines of vagina, ectocervix and endocervix | Co-culture |
Colorimetric assay ECL assay Quantikine ELISA |
Pathogen-Host Cells-Microbiota | Antagonist interaction: TV vs. Lactobacillus spp. Synergic interaction: TV vs. bacteria BV-associated | 50 |
| G. vaginalis, Candida albicans, L. plantarum, and L. fermentum/BV and VVC | HeLa | Co-incubation (Pre-treatment post-treatment) |
ELISA Luciferase assay |
Microbiota-Host cells | Anti-inflammatory effect of Lactobacillus spp. | 54 |
| C. glabrata and L. fermentum, L. casei, L. crispatus, L. paracasei, L. gasseri, and L. Rhamnosus/VVC | - | Co-culture | Fluorescence microscopy CFU counts | Pathogen-Microbiota | Mechanism by Candida for tolerating environmental stress | 41 |
| T. vaginalis and Escherichia coli/Trichomoniasis | - | Co-incubation | RT-qPCR | Pathogen-Microbiota | Mechanism by TV interacts with microbiota | 47 |
| T. vaginalis/Trichomoniasis | - | Transwell co-culture | Flow cytometry Gene knockout and adding back of TvMIF in TV | Pathogen-Pathogen | Mechanism of TV survival under nutrient stress | 71 |
| C. albicans, L. gasseri, L. rhamnosus, L. acidophilus, and L. paracasei/VVC | - | Co-incubation Pre-incubation | Antagonism assay Crystal violet assay | Pathogen-Microbiota | Antifungal and antivirulence activity of Lactobacillus spp. | 40 |
| C. albicans, G. vaginalis, and Chlamydia trachomatis/Chlamydia infection | HeLa | Transwell co-culture | Crystal violet assay | Microbiota-Pathogen-Host cell | C. albicans and G. vaginalis biofilms as a reservoir of C. trachomatis | 64 |
| Streptococcus agalactiae, L. reuteri, L. gasseri, and L. crispatus/Neonatal infections | Human endometrial stromal cells | Co-culture | CFU counts Fluorescent nucleic acid stain | Microbiota-Pathogen-Host cell | Secreted products of Lactobacillus spp. inhibited GBS growth, biofilm formation and invasion of host cells | 53 |
| G. vaginalis and L. crispatus/BV | Epithelial cells lines of vagina, ectocervix and endocervix | Co‐culture |
Imaging LDH assay qPCR ELISA |
Microbiota-Pathogen-Host cell | G. vaginalis induces cell death and immune responses, but not L. crispatus | 55 |
| C. parapsilosis, L. acidophilus, L. plantarum, L. rhamnosus, and L. reuteri/VVC | Vaginal epithelial squamous cell carcinoma | Transwell co-culture |
Imaging LDH assay XTT analysis |
Pathogen-Microbiota | CFS of Lactobacillus spp. inhibits in vitro infection by C. parapsilosis | 68 |
| C. albicans and E. coli/VVC | - | Co-culture |
Crystal violet XTT assays |
Dual species biofilm (Yeast- Bacteria) | E. coli modulates biofilm of C. albicans | 58 |
| T. vaginalis, L. gasseri, and G. vaginalis/Trichomoniasis and BV | - | Co-incubation |
CFU counts RT-qPCR Enzymatic assay |
Microbiota-Pathogen | Mechanism of TV interaction with microbiota | 48 |
| C. albicans, Rhodotorula mucilaginosa, Malassezia furfur, and Naganishia albida/VVC | - | Co-culture |
Crystal violet assay MTT assay Hemocytometer counts |
Dual species biofilm | Ecological relationship within yeast microbiota enhances pathogenicity during co-culture | 59 |
| L. crispatus, L. gasseri, and L. jensenii and G. vaginalis/BV | - | Transwell Co-culture |
TEM Quantification of L- and D-lactic acid and H2O2 |
Pathogen-Microbiota | L. jensenii produces a bactereriocin-like substance that inhibits G. vaginalis | 67 |
| T. vaginalis, G. vaginalis, P. bivia, and Atopobium vaginae /BV and Trichomoniasis | Ects | Transwell co-culture |
Fluorescence qPCR LDH assay |
Pathogen-Microbiota-Host cell | Mechanism of cytotoxicity by TV and BV-associated bacteria | 66 |
| C. trachomatis, L. crispatus, L. jensenii, L. gasseri, L. iners, and G. vaginalis/ C. trachomatis infection | Fibroblasts and cervical epithelial cells | Transwell system |
Lactic acid measure Immunofluorescence staining Imaging Confocal |
Pathogen-Microbiota-Host cell | Microbiota modulates C. trachomatis infection | 65 |
| T. vaginalis, S. agalactiae, and L. iners/vaginitis | - | Co-culture |
CFU counts Hemocytometer counts |
Pathogen-Microbiota | Impact of microbiota composition on T. vaginalis infection | 43 |
| L. crispatus and C. albicans/CVV | - | Transwell co-culture | CFU counts | Yeast-Microbiota | Mechanism by C. albicans alkalinizes an acidic environment | 74 |
PubMed was chosen as the information source, and Medical Subject Headings (MESH) terms were used to search the vocabulary thesaurus. The keywords and search strategy applied were: “Co-culture” OR “Coculture” OR ‘Cocultivation’ OR ‘Co-incubation’ AND ‘Trichomonas vaginalis’ OR ‘Candida spp.’ OR ‘Lactobacillus spp.’. This search yielded 365 articles, of which 19 were selected for this review. The selection criteria required articles to be relevant to vaginal health, written in English, and accessible. The screening process involved examining the materials and methods sections, and only studies employing co-culture or co-incubation techniques within the past 24 years were included.
CO-CULTURE APPLILCATONS IN THE STUDY OF VAGINAL HEALTH
Co-cultures techniques enable the simultaneous cultivation of different cell populations, offering advantages over monocultures by more accurately mimicking real-life conditions 33. This approach allows for the study of both cell-cell and drug-cell interactions, the latter being particularly valuable for drug research by providing an in vivo-like cell culture model 34. Additionally, co-culture methods facilitate the investigation of microbial interactions, helping to elucidate patterns of interaction and the ability of resident microbiota to either inhibit or promote the growth of pathogens or opportunist organisms 35. Such studies are particularly relevant in microbiota - host - pathogen interactions. The most used techniques include CLM and membrane separation, particularly Transwell system.
Communal liquid medium growth (CLM)
CLM is widely used to study microbial interactions, substance production, and over- or under-yielding in co-culture by varying inoculation ratios and incubation times 36. In this system, direct mixing enhances interactions and molecular exchange compared to monoculture 37. Alternatively, biofilm formation with multiple species in the same medium allows for the exploration of regulatory factors and microorganism interrelationships 38.
Among the key microbial players in the vaginal environment, Lactobacillus spp. play a crucial role in maintaining an acidic pH producing lactic acid, which restricts the growth of opportunistic microbes. Beyond acidification, lactobacilli inhibit pathogen adherence, limit nutrient availability, and exert a fungistatic effect on Candida spp., preventing yeast overgrowth 39.
The protective role of Lactobacillus spp. is further supported by studies on their antimicrobial metabolites. Itapary dos Santos et al. (2019) demonstrated the antifungal and antivirulence potential of metabolites produced by vaginal lactobacilli, including L. gasseri, Lactobacillus rhamnosus, Lactobacillus acidophilus and Lactobacillus paracasei. Among the 20 strains tested, 15 secreted biosurfactants that reduced C. albicans biofilm formation and adhesion 40. In contrast, another study identified a mechanism that enables C. glabrata—the second most common species associated with VVC—to withstand environmental stressors such as osmotic stress, low pH, and exposure to carboxylic acids. The virulence of C. glabrata is linked to the high osmolarity glycerol (HOG) response pathway, which enhances its survival under acidic conditions created by lactic and other weak carboxylic acids from Lactobacillus spp., as well as provides protection against oxidative stress induced by macrophage activity 41.
However, not all Lactobacillus species contribute equally to vaginal health. L. iners, for instance, lacks the capacity to produce hydrogen peroxide, and its lactic acid production is significantly diminished 42. A study demonstrated that in a co-culture with T. vaginalis, L. iners initially exhibited reduced growth. However, it appears to adapt to the stress conditions imposed by the protozoan and can survive prolonged incubation periods 43. L. iners is frequently found in the vaginal microbiota of women with bacterial vaginosis 44 and, due to its weak probiotic activity, a microbiota dominated by L. iners is associated with STIs and adverse pregnancy outcomes 45.
Bacterial vaginosis (BV) affects reproductive-age women, with 50% of cases being asymptomatic, increasing the risk of acquiring HIV, Neisseria gonorrhea, T. vaginalis, and other STIs 46. A study using a bacterial colonization model explored the interaction between BV-associated bacteria and T. vaginalis. Epithelial cells were colonized by Lactobacillus spp., Gardnerella vaginalis, or Prevotella bivia, then co-infected with T. vaginalis. The results showed that T. vaginalis reduced colonization of epithelial cells by L. acidophilus, Lactobacillus crispatus, and L. jensenii. Additionally, the interaction between G. vaginalis, P. bivia, and T. vaginalis was found to modulate the immune system, amplifying pro-inflammatory responses 47.
Beyond interactions with lactobacilli, T. vaginalis also engages in cooperative relationships with anaerobic bacteria such as G. vaginalis, Atopobium vaginae, and P. bivia 48. This cooperation is likely driven by lateral gene transfer, through which T. vaginalis acquired genes from the N1pC/P60 family, known for their role in bacterial peptidoglycan hydrolysis. Co-culture studies with Escherichia coli, a vaginal microbiota member, have shown that T. vaginalis exploits bacterial interactions to enhance infection progression. In the presence of bacteria, N1pC/P60 proteins in T. vaginalis are upregulated, increasing protozoan persistence in mixed cultures 49.
Additionally, co-incubation of T. vaginalis with L. gasseri reduces bacterial colony-forming units (CFU), triggered protozoan aggregation, and induced upregulation of TvN1pC gene expression. However, these proteins did not inhibit the growth of G. vaginalis, suggesting a specific role in disrupting vaginal microbiota balance 50. This study establishes N1pC/P60-containing peptidases as key effectors in T. vaginalis interactions with the vaginal microbiota, particularly lactobacilli. These enzymes facilitate bacterial degradation both extracellularly and post-phagocytosis, reinforcing the parasite’s ability to manipulate its microbial environment for survival and persistence.
Neonatal infections caused by Group B Streptococcus (GBS) are linked to an increased risk of premature birth and stillbirth 51. GBS can asymptomatically colonize pregnant women, creating a risk of transmission to newborn during childbirth, particularly by aspiration 52. A study investigating the influence of the vaginal microbiota on invasive GBS strains their interaction with human endometrial cells in co-culture with various Lactobacillus strains and their supernatants. While live Lactobacillus spp. did not significantly impact GBS growth or biofilm formation, the secreted supernatants effectively inhibited GBS growth, biofilm development, and cellular invasion 53.
The vaginal microbiota plays a crucial role in protecting against pathogens, though its effectiveness depends on the specific microorganisms present. A cell model infected with G. vaginalis or C. albicans was used to evaluate the immunomodulatory effects of two Lactobacillus species. The results demonstrated that Lactobacillus spp. reduced the release of pro-inflammatory cytokines and suppressed NF-kB activation, a process typically triggered when G. vaginalis or C. albicans interact with HeLa cells 54. Similarly, a co-culture model of L. crispatus or G. vaginalis with endocervical, ectocervical or vaginal cells revealed that G. vaginalis induced cell death, compromised cell integrity, and triggered an epithelial immune response through NF-kB activation and increased pro-inflammatory cytokine release. In contrast, L. crispatus maintained epithelial barrier integrity and did not induce inflammatory response 55.
Microbial interactions within the vaginal microbiota further influence infection dynamics, particularly through biofilm formation, a process that enhances survival and resistance to antimicrobial agents. Many fungi, including those from the genera Candida, Clavispora, Malassezia, Rhodotorula, Aspergillus, and Leptosphaerulina, coexist in this environment, fostering interactions that may contribute to pathogenicity 56,57. Candida species, for instance can form heterogeneous biofilms with other microorganisms 58. C. albicans has been shown to interact with Malassezia spp., suggesting a symbiotic relationship characterized by increased fungal growth, mixed biofilms, and enhanced germ tube formation during co-culture 59.
Understanding microbial interactions within biofilms is essential, as biofilms exhibit inherent resistance to antimicrobial agents, complicating the treatment of co-occurring infections 60. In a dual-species biofilm involving various Candida species and Pseudomonas aeruginosa, the presence of bacteria inhibited biofilm formation, as indicated by a reduction in CFU for both Candida spp. and P. aeruginosa. The sparse biofilm architecture was confirmed using scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM) 61. Another study assessed the effect of E. coli on C. albicans biofilm formation using vaginal swab isolates. The results showed a reduction in biofilm formation, as observed through CLSM and SEM, suggesting that E. coli may function as a microbial reservoir that influences C. albicans biofilm development 62.
Permeable membrane technique
The permeable membrane technique (Transwell system®) utilizes a permeable membrane in multi-well plates to separate cells, enabling the exchange of signaling molecules without direct contact 38. This polycarbonate membrane divides the system into an upper insert and a lower reservoir. While the system is easy to set up and requires only a small culture volume, careful selection of membrane porosity is essential to ensure proper metabolite diffusion. This co-culture method mimics in vivo conditions, facilitating the identification of extracellular molecules released during interactions 63. Leveraging this system allows for deeper insights into host-pathogen interactions, the antimicrobial properties of Lactobacillus spp., and the persistence mechanisms of vaginal pathogens.
The interaction between Chlamydia trachomatis and biofilms of C. albicans or G. vaginalis was investigated using a Transwell co-culture system, where biofilms were placed on the upper platform and a Hela cell monolayer on the lower part. The results demonstrated that C. trachomatis could survive within the biofilm while still inducing inclusions in the cell monolayer, confirming that it retains its infectious proprieties within the biofilm 64. Further studies using a three-dimensional cervical epithelium model, composed of fibroblasts, epithelial cells, and various Lactobacillus species, revealed that Lactobacillus spp. producing D-lactic acid provided protection against C. trachomatis. In contrast, L. iners, which does not produce this isoform, was associated with increased susceptibility to infection, suggesting that women with an L. iners-dominated microbiota are more vulnerable to chlamydial infection 65.
A polymicrobial infection model employing the Transwell system assessed the influence of T. vaginalis and BV-associated bacteria on the paracellular permeability of ectocervical cells (hECs). The BV-associated bacteria including G. vaginalis, P. bivia, and A. vaginae, are key members of the CST-IV vaginal microbiota group. The study found that these microorganisms collectively increased the paracellular permeability of hECs, elevated phosphatase activity - indicating compromised monolayer integrity - and upregulated the expression of tight junction proteins and pro-inflammatory cytokines (IL-6 and TNF- α). These findings underscore the microbiota’s significant role in trichomoniasis pathogenesis 66.
The antimicrobial potential of Lactobacillus spp. against vaginal pathogens has also been explored using Transwell co-culture systems. One study found that L. jensenii produces a bacteriocin-like substance with specific bactericidal activity against G. vaginalis, Gardnerella piotii, and Gardnerella leopoldii, without affecting the growth of other uropathogens or Lactobacillus species such as L. crispatus and L. gasseri 67. Another study evaluated the antimicrobial properties of L. acidophilus, Lactobacillus plantarum, L. rhamnosus, and Lactobacillus reuteri against Candida parapsilosis in a co-culture system comprising vaginal epithelial cells, bacteria, and yeast. The results demonstrated that all tested Lactobacillus species inhibited the virulence factors of C. parapsilosis by reducing its proliferation, viability, and metabolic activity, suggesting a postbiotic-like protective effect against those mucosal infections 68.
The pathogens have acquired mechanisms for persistence in the vaginal environment though interactions with the host. Human macrophage migration inhibitory factor (huMIF) plays a crucial role in regulating cell growth and survival 69. T. vaginalis shares a homologous protein with its host, known as TvMIF, which enhances the protozoan’s survival during nutrient starvation 70,71.
To investigate the role of this protein, a Transwell co-culture system was employed, in which parasites overexpressing TvMIF were separated by a membrane from those carrying an empty vector. Under serum starvation, the TvMIF-overexpressing parasites exhibited significantly increased survival, whereas TvMIF knockout reduced parasite viability. This survival mechanism is activated under nutrient deprivation, as TvMIF expression and secretion are upregulated. Secreted TvMIF enhances parasite survival through an intracellular positive-feedback loop that promotes its own expression and secretion. Additionally, TvMIF inhibits apoptosis, facilitating parasite persistence in the urogenital tract — an otherwise unfavorable environment. Chen et al. (2018) demonstrated that this conserved protein plays a crucial role in parasite survival and mediated host-pathogen crosstalk 71. The metabolic activities of vaginal microorganisms further shape microbial interactions. C. albicans, for example, metabolizes amino acids, leading to ammonia accumulation and subsequent alkalinization of the vaginal environment 72. This pH shift promotes C. albicans’ transition from yeast to filamentous growth, a key virulence factor 73. A study using a Transwell co-culture system examined whether ammonia production by C. albicans affects the growth of L. crispatus, a known fungal antagonist. The results showed that L. crispatus growth remained unaffected by the alkalinization caused by C. albicans, suggesting that other mechanisms contribute to dysbiosis in the vaginal ecosystem 74.
By utilizing Transwell-based co-culture models, researchers continue to uncover the complex interplay between the vaginal microbiota and pathogens, shedding light on protective and pathogenic mechanisms that influence vaginal health.
CONCLUSION
Co-culture systems provide valuable insights into microbial interactions, including gene and protein crosstalk, the influence of microbiota on pathogen persistence within the host, producing antimicrobial substances or disease-promoting factors. Over the past 24 years, co-culture and co-incubation techniques have significantly advanced our understanding of the complex interactions among microbiota, host cells, pathogens, and biofilms. This review focuses on studies related to trichomoniasis, bacterial vaginosis, chlamydia, neonatal infections, and mixed biofilms, emphasizing the critical role of microbiota composition in infection dynamics and host defense mechanisms. While some microorganisms counteract pathogen colonization, others interact with opportunistic microbes, increasing disease pathogenicity and complicating treatment strategies. Co-culture techniques have been instrumental in studying pathogen virulence factors, immune cells responses to infections, and the ecological interactions that contribute to pathogenicity in the reproductive tract. Furthermore, these platforms could serve as effective models for mimicking the in vivo environment in laboratory settings. Moving forward, co-culture models will continue to be a powerful tool for unraveling pathogen dynamics and developing more effective therapeutic approaches.
CONFLICT OF INTEREST
The authors declare no conflicts of interest.
Funding Statement
This study was supported by the Brazilian agencies Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior CAPES) - Programa de Pós-Graduação em Ciências Farmacêuticas, and Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS). T.T. thanks CNPq for the researcher fellowship (grant 09764/2021-1). This study is part of the National Institute of Science and Technology in 3D printing and Advanced Materials Applied to Human and Veterinary Health - INCT _3D-Saúde, funded by CNPq, Brazil (Grant #406436/2022-3).
REFERENCES
- 1.Martin DH. The microbiota of the vagina and its influence on women's health and disease. Am J Med Sci. 2012;343:2–9. doi: 10.1097/MAJ.0b013e31823ea228. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Chen X, Lu Y, Chen T, Li R. The Female Vaginal Microbiome in Health and Bacterial Vaginosis. Front Cell Infect Microbiol. 2021;1:631972. doi: 10.3389/fcimb.2021.631972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.France MT, Ma B, Gajer P, Brown S, Humphrys MS, Holm JB, Waetjen LE, Brotman RM, Ravel J. VALENCIA: a nearest centroid classification method for vaginal microbial communities based on composition. Microbiome. 2020;8:166. doi: 10.1186/s40168-020-00934-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kalia N, Singh J, Kaur M. Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: a critical review. Ann Clin Microbiol Antimicrob. 2020;19:5. doi: 10.1186/s12941-020-0347-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Brotman RM, Bradford LL, Conrad M, Gajer P, Ault K, Peralta L, Forney LJ, Carlton JM, Abdo Z, Ravel J. Association between Trichomonas vaginalis and vaginal bacterial community composition among reproductive-age women. Sex Transm Dis. 2012;39:807–812. doi: 10.1097/OLQ.0b013e3182631c79. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Willems HME, Ahmed SS, Liu J, Xu Z, Peters BM. Vulvovaginal Candidiasis: A Current Understanding and Burning Questions. J Fungi. 2020;6:27. doi: 10.3390/jof6010027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.liev ID, Underhill DM. Striking a balance: fungal commensalism versus pathogenesis. Curr Opin Microbiol. 2013;16:366–373. doi: 10.1016/j.mib.2013.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA. 2004;291:1368–1379. doi: 10.1001/jama.291.11.1368. [DOI] [PubMed] [Google Scholar]
- 9.Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18:e339–e347. doi: 10.1016/S1473-3099(18)30103-8. [DOI] [PubMed] [Google Scholar]
- 10.Bauters TG, Dhont MA, Temmerman MI, Nelis HJ. Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am J Obstet Gynecol. 2002;187:569–574. doi: 10.1067/mob.2002.125897. [DOI] [PubMed] [Google Scholar]
- 11.Villa S, Hamideh M, Weinstock A, Qasim MN, Hazbun TR, Sellam A, Hernday AD, Thangamani S. Transcriptional control of hyphal morphogenesis in Candida albicans. FEMS Yeast Res. 2020;20:foaa005. doi: 10.1093/femsyr/foaa005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Brown GD. Innate antifungal immunity: the key role of phagocytes. Ann Rev Immunol. 2011;29:1–21. doi: 10.1146/annurev-immunol-030409-101229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Erwig LP, Gow NA. Interactions of fungal pathogens with phagocytes. Nat Rev Microbiol. 2016;14:163–176. doi: 10.1038/nrmicro.2015.21. [DOI] [PubMed] [Google Scholar]
- 14.Huse M. Mechanical forces in the immune system. Nat Rev Immunol. 2017;17(11):679–690. doi: 10.1038/nri.2017.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Austermeier S, Kasper L, Westman J, Gresnigt MS. I want to break free - macrophage strategies to recognize and kill Candida albicans, and fungal counter-strategies to escape. Curr Opin Microbiol. 2020;58:15–23. doi: 10.1016/j.mib.2020.05.007. [DOI] [PubMed] [Google Scholar]
- 16.Chang HT, Tsai PW, Huang HH, Liu YS, Chien TS, Lan CY. LL37 and hBD-3 elevate the β-1,3-exoglucanase activity of Candida albicans Xog1p, resulting in reduced fungal adhesion to plastic. Biochem J. 2012;441(3):963–970. doi: 10.1042/BJ20111454. [DOI] [PubMed] [Google Scholar]
- 17.Swidergall M, Ernst JF. Interplay between Candida albicans and the antimicrobial peptide armory. Eukaryot Cell. 2014;13(8):950–957. doi: 10.1128/EC.00093-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Swidergall M, Khalaji M, Solis NV, Moyes DL, Drummond RA, Hube B, Lionakis MS, Murdoch C, Filler SG, Naglik JR. Candidalysin Is Required for Neutrophil Recruitment and Virulence During Systemic Candida albicans Infection. J Infect Dis. 2019;220(9):1477–1488. doi: 10.1093/infdis/jiz322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, Chico RM, Smolak A, Newman L, Gottlieb S, Thwin SS, Broutet N, Taylor MM. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97:548–562P. doi: 10.2471/BLT.18.228486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70:1–187. doi: 10.15585/mmwr.rr7004a1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Mielczarek E, Blaszkowska J. Trichomonas vaginalis: pathogenicity and potential role in human reproductive failure. Infection. 2016;44:447–458. doi: 10.1007/s15010-015-0860-0. [DOI] [PubMed] [Google Scholar]
- 22.Dunne RL, Dunn LA, Upcroft P, O'Donoghue PJ, Upcroft JA. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis. Cell Res. 2003;13:239–249. doi: 10.1038/sj.cr.7290169. [DOI] [PubMed] [Google Scholar]
- 23.Netea MG, Schlitzer A, Placek K, Joosten LAB, Schultze JL. Innate and Adaptive Immune Memory: an Evolutionary Continuum in the Host's Response to Pathogens. Cell Host Microbe. 2019;25(1):13–26. doi: 10.1016/j.chom.2018.12.006. [DOI] [PubMed] [Google Scholar]
- 24.Galego GB, Tasca T. Infinity war: Trichomonas vaginalis and interactions with host immune response. Microbial Cell. 2023;10(5):103–116. doi: 10.15698/mic2023.05.796. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Lehker MW, Sweeney D. Trichomonad invasion of the mucous layer requires adhesins, mucinases, and motility. Sex Transm Infect. 1999;75(4):231–238. doi: 10.1136/sti.75.4.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Figueroa-Ângulo EE, Rendón-Gandarilla FJ, Puente-Rivera J, Calla-Choque JS, Cárdenas-Guerra RE, Ortega-López J, Quintas-Granados LI, Alvarez-Sánchez ME, Arroyo R. The effects of environmental factors on the virulence of Trichomonas vaginalis. Microbes Infect. 2012;14(15):1411–1427. doi: 10.1016/j.micinf.2012.09.004. [DOI] [PubMed] [Google Scholar]
- 27.Yamaguchi Y, Kudoh J, Yoshida T, Shimizu N. In vitro co-culture systems for studying molecular basis of cellular interaction between Aire-expressing medullary thymic epithelial cells and fresh thymocytes. Biol Open. 2014;3:1071–1082. doi: 10.1242/bio.201410173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Sanitá Lima M, Coutinho de Lucas R. Co-cultivation, Co-culture, Mixed Culture, and Microbial Consortium of Fungi: An Understudied Strategy for Biomass Conversion. Front Microbiol. 2022;12:837685. doi: 10.3389/fmicb.2021.837685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Lehker MW, Alderete JF. Properties of Trichomonas vaginalis grown under chemostat controlled growth conditions. Genitourin Med. 1990;66:193–199. doi: 10.1136/sti.66.3.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Dabrowa N, Landau JW, Newcomer VD. Generation time of Candida albicans in synchronized and nonsynchronized cultures. J Med Vet Mycol. 1968;6:51–56. doi: 10.1080/00362176885190091. [DOI] [Google Scholar]
- 31.Mohd Isa NS, El Kadri H, Vigolo D, Gkatzionis K. The Effect of Bacteria on the Stability of Microfluidic-Generated Water-in-Oil Droplet. Micromachines. 2022;13:2067. doi: 10.3390/mi13122067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Owens RB, Smith HS, Nelson-Rees WA, Springer EL. Epithelial cell cultures from normal and cancerous human tissues. J Natl Cancer Inst. 1976;56:843–849. doi: 10.1093/jnci/56.4.843. [DOI] [PubMed] [Google Scholar]
- 33.Goers L, Freemont P, Polizzi KM. Co-culture systems and technologies: taking synthetic biology to the next level. J R Soc Interface. 2014;11:20140065. doi: 10.1098/rsif.2014.0065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Wu MH, Huang SB, Lee GB. Microfluidic cell culture systems for drug research. Lab Chip. 2010;10:939–956. doi: 10.1039/b921695b. [DOI] [PubMed] [Google Scholar]
- 35.Temkin MT, Carlson CM, Stubbendieck AL, Currie CR, Stubbendieck RM. High Throughput Co-culture Assays for the Investigation of Microbial Interactions. J Vis Exp. 2019;152:10.3791/60275. doi: 10.3791/60275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Padmaperuma G, Kapoore RV, Gilmour DJ, Vaidyanathan S. Microbial consortia: a critical look at microalgae co-cultures for enhanced biomanufacturing. Crit Rev Biotechnol. 2018;38:690–703. doi: 10.1080/07388551.2017.1390728. [DOI] [PubMed] [Google Scholar]
- 37.Brenner K, You L, Arnold FH. Engineering microbial consortia: a new frontier in synthetic biology. Trends Biotechnol. 2008;26:483–489. doi: 10.1016/j.tibtech.2008.05.004. [DOI] [PubMed] [Google Scholar]
- 38.Kapoore RV, Padmaperuma G, Maneein S, Vaidyanathan S. Co-culturing microbial consortia: approaches for applications in biomanufacturing and bioprocessing. Crit Rev Biotechnol. 2022;42:46–72. doi: 10.1080/07388551.2021.1921691. [DOI] [PubMed] [Google Scholar]
- 39.Hütt P, Lapp E, Štšepetova J, Smidt I, Taelma H, Borovkova N, Oopkaup H, Ahelik A, Rööp T, Hoidmets D, Samuel K, Salumets A, Mändar R. Characterization of probiotic properties in human vaginal lactobacilli strains. Microb Ecol Health Dis. 2016;27:30484. doi: 10.3402/mehd.v27.30484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Itapary Dos Santos C, Ramos França Y, Duarte Lima Campos C, Quaresma Bomfim MR, Oliveira Melo B, Assunção Holanda R, Santos VL, Gomes Monteiro S, Buozzi Moffa E, Souza Monteiro A, Andrade Monteiro C, Monteiro-Neto V. Antifungal and Antivirulence Activity of Vaginal Lactobacillus spp. Products against Candida Vaginal Isolates. Pathogens. 2019;8:150. doi: 10.3390/pathogens8030150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Beyer R, Jandric Z, Zutz C, Gregori C, Willinger B, Jacobsen ID, Kovarik P, Strauss J, Schüller C. Competition of Candida glabrata against Lactobacillus is Hog1 dependent. Cell Microbiol. 2018;20:e12943. doi: 10.1111/cmi.12943. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Petricevic L, Domig KJ, Nierscher FJ, Sandhofer MJ, Fidesser M, Krondorfer I, Husslein P, Kneifel W, Kiss H. Characterization of the vaginal Lactobacillus microbiota associated with preterm delivery. Sci Rep. 2014;4:5136. doi: 10.1038/srep05136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Chiu SF, Huang PJ, Cheng WH, Huang CY, Chu LJ, Lee CC, Lin HC, Chen LC, Lin WN, Tsao CH, Tang P, Yeh YM, Huang KY. Vaginal Microbiota of the Sexually Transmitted Infections Caused by Chlamydia trachomatis and Trichomonas vaginalis in Women with Vaginitis in Taiwan. Microorganisms. 2021;9:1864. doi: 10.3390/microorganisms9091864. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Ferris MJ, Norori J, Zozaya-Hinchliffe M, Martin DH. Cultivation-independent analysis of changes in bacterial vaginosis flora following metronidazole treatment. J Clin Microbiol. 2007;45:1016–1018. doi: 10.1128/JCM.02085-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Zheng N, Guo R, Wang J, Zhou W, Ling Z. Contribution of Lactobacillus iners to Vaginal Health and Diseases: A Systematic Review. Front Cell Infect Microbiol. 2021;11:792787. doi: 10.3389/fcimb.2021.792787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Coudray MS, Madhivanan P. Bacterial vaginosis-A brief synopsis of the literature. Eur J Obstet Gynecol Reprod Biol. 2020;245:143–148. doi: 10.1016/j.ejogrb.2019.12.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Fichorova RN, Buck OR, Yamamoto HS, Fashemi T, Dawood HY, Fashemi B, Hayes GR, Beach DH, Takagi Y, Delaney ML, Nibert ML, Singh BN, Onderdonk AB. The villain team-up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert. Sex Transm Infect. 2013;89:460–466. doi: 10.1136/sextrans-2013-051052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Bär AK, Phukan N, Pinheiro J, Simoes-Barbosa A. The Interplay of Host Microbiota and Parasitic Protozoans at Mucosal Interfaces: Implications for the Outcomes of Infections and Diseases. PLoS Negl Trop Dis. 2015;9:e0004176. doi: 10.1371/journal.pntd.0004176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Pinheiro J, Biboy J, Vollmer W, Hirt RP, Keown JR, Artuyants A, Black MM, Goldstone DC, Simoes-Barbosa A. The Protozoan Trichomonas vaginalis Targets Bacteria with Laterally Acquired NlpC/P60 Peptidoglycan Hydrolases. mBio. 2018;9:e01784–e01718. doi: 10.1128/mBio.01784-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Barnett MJ, Pinheiro J, Keown JR, Biboy J, Gray J, Lucinescu IW, Vollmer W, Hirt RP, Simoes-Barbosa A, Goldstone DC. NlpC/P60 peptidoglycan hydrolases of Trichomonas vaginalis have complementary activities that empower the protozoan to control host-protective lactobacilli. PLoS Pathog. 2023;19:1011563. doi: 10.1371/journal.ppat.1011563. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Verani JR, McGee L, Schrag SJ. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59:1–36. [PubMed] [Google Scholar]
- 52.Romero R, Gomez-Lopez N, Winters AD, Jung E, Shaman M, Bieda J, Panaitescu B, Pacora P, Erez O, Greenberg JM, Ahmad MM, Hsu CD, Theis KR. Evidence that intra-amniotic infections are often the result of an ascending invasion - a molecular microbiological study. J Perinat Med. 2019;47:915–931. doi: 10.1515/jpm-2019-0297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Shiroda M, Aronoff DM, Gaddy JA, Manning SD. The impact of Lactobacillus on group B streptococcal interactions with cells of the extraplacental membranes. Microb Pathog. 2020;148:104463. doi: 10.1016/j.micpath.2020.104463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Santos CMA, Pires MCV, Leão TL, Silva AKS, Miranda LS, Martins FS, Silva AM, Nicoli JR. Anti-inflammatory effect of two Lactobacillus strains during infection with Gardnerella vaginalis and Candida albicans in a HeLa cell culture model. Microbiology. 2018;164:349–358. doi: 10.1099/mic.0.000608. [DOI] [PubMed] [Google Scholar]
- 55.Anton L, Ferguson B, Friedman ES, Gerson KD, Brown AG, Elovitz MA. Gardnerella vaginalis alters cervicovaginal epithelial cell function through microbe-specific immune responses. Microbiome. 2022;10:119. doi: 10.1186/s40168-022-01317-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Lehtoranta L, Hibberd AA, Yeung N, Laitila A, Maukonen J, Ouwehand AC. Characterization of vaginal fungal communities in healthy women and women with bacterial vaginosis (BV); a pilot study. Microb Pathog. 2021;161:105055. doi: 10.1016/j.micpath.2021.105055. [DOI] [PubMed] [Google Scholar]
- 57.Caetano CF, Gaspar C, Martinez-de-Oliveira J, Palmeira-de-Oliveira A, Rolo J. The Role of Yeasts in Human Health: A Review. Life. 2023;13:924. doi: 10.3390/life13040924. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Diaz PI, Strausbaugh LD, Dongari-Bagtzoglou A. Fungal-bacterial interactions and their relevance to oral health: linking the clinic and the bench. Front Cell Infect Microbiol. 2014;4:101. doi: 10.3389/fcimb.2014.00101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Caetano CF, Gaspar C, Oliveira AS, Palmeira-de-Oliveira R, Rodrigues L, Gonçalves T, Martinez-de-Oliveira J, Palmeira-de-Oliveira A, Rolo J. Study of Ecological Relationship of Yeast Species with Candida albicans in the Context of Vulvovaginal Infections. Microorganisms. 2023;11:2398. doi: 10.3390/microorganisms11102398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 2001;9:34–39. doi: 10.1016/s0966-842x(00)01913-2. [DOI] [PubMed] [Google Scholar]
- 61.Bandara HM, Yau JY, Watt RM, Jin LJ, Samaranayake LP. Pseudomonas aeruginosa inhibits in-vitro Candida biofilm development. BMC Microbiol. 2010;10:125. doi: 10.1186/1471-2180-10-125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Díaz-Navarro M, Irigoyen Von-Sierakowski Á, Palomo M, Escribano P, Guinea J, Burillo A, Galar A, Muñoz P, Guembe M. In vitro study to assess modulation of Candida biofilm by Escherichia coli from vaginal strains. Biofilm. 2023;5:100116. doi: 10.1016/j.bioflm.2023.100116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Yoo J, Jung Y, Char K, Jang Y. Advances in cell coculture membranes recapitulating in vivo microenvironments. Trends Biotechnol. 2023;41:214–227. doi: 10.1016/j.tibtech.2022.07.014. [DOI] [PubMed] [Google Scholar]
- 64.Filardo S, Di Pietro M, Tranquilli G, Sessa R. Biofilm in Genital Ecosystem: A Potential Risk Factor for Chlamydia trachomatis Infection. Can J Infect Dis Med Microbiol. 2019;2019:1672109. doi: 10.1155/2019/1672109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Edwards VL, Smith SB, McComb EJ, Tamarelle J, Ma B, Humphrys MS, Gajer P, Gwilliam K, Schaefer AM, Lai SK, Terplan M, Mark KS, Brotman RM, Forney LJ, Bavoil PM, Ravel J. The Cervicovaginal Microbiota-Host Interaction Modulates Chlamydia trachomatis Infection. mBio. 2019;10:e01548–e01519. doi: 10.1128/mBio.01548-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Hinderfeld AS, Phukan N, Bär AK, Roberton AM, Simoes-Barbosa A. Cooperative Interactions between Trichomonas vaginalis and Associated Bacteria Enhance Paracellular Permeability of the Cervicovaginal Epithelium by Dysregulating Tight Junctions. Infect Immun. 2019;87:e00141–e00119. doi: 10.1128/IAI.00141-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Navarro S, Abla H, Colmer-Hamood JA, Ventolini G, Hamood AN. Under conditions closely mimicking vaginal fluid, Lactobacillus jensenii strain 62B produces a bacteriocin-like inhibitory substance that targets and eliminates Gardnerella species. Microbiology. 2023;169:001409. doi: 10.1099/mic.0.001409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Spaggiari L, Sala A, Ardizzoni A, De Seta F, Singh DK, Gacser A, Blasi E, Pericolini E. Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System In Vitro. Microbiol Spectr. 2022;10:e0269621. doi: 10.1128/spectrum.02696-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003;3:791–800. doi: 10.1038/nri1200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Twu O, de Miguel N, Lustig G, Stevens GC, Vashisht AA, Wohlschlegel JA, Johnson PJ. Trichomonas vaginalis exosomes deliver cargo to host cells and mediate host-parasite interactions. PLoS Pathog. 2013;9:e1003482. doi: 10.1371/journal.ppat.1003482. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Chen YP, Twu O, Johnson PJ. Trichomonas vaginalis Macrophage Migration Inhibitory Factor Mediates Parasite Survival during Nutrient Stress. mBio. 2018;9:e00910–e00918. doi: 10.1128/mBio.00910-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Vylkova S, Carman AJ, Danhof HA, Collette JR, Zhou H, Lorenz MC. The fungal pathogen Candida albicans autoinduces hyphal morphogenesis by raising extracellular pH. mBio. 2011;2:e00055–e00011. doi: 10.1128/mBio.00055-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Kasper L, Seider K, Gerwien F, Allert S, Brunke S, Schwarzmüller T, Ames L, Zubiria-Barrera C, Mansour MK, Becken U, Barz D, Vyas JM, Reiling N, Haas A, Haynes K, Kuchler K, Hube B. Identification of Candida glabrata genes involved in pH modulation and modification of the phagosomal environment in macrophages. PLoS One. 2014;9:e96015. doi: 10.1371/journal.pone.0096015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Silao FGS, Valeriano VD, Uddström E, Falconer E, Ljungdahl PO. Diverse mechanisms control amino acid-dependent environmental alkalization by Candida albicans. Mol Microbiol. 2024;121:696–716. doi: 10.1111/mmi.15216. [DOI] [PubMed] [Google Scholar]
